Screen of drug use: Diagnostic accuracy for cannabis use disorder

Addictive Behaviors

Volumn 95, Issue , 2019, Pages 184-188

  Tiet, Quyen Q ^a,b   Leyva, Yani E ^a   Browne, Kendall ^c,d,e   Moos, Rudolf H ^f  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b ALLIANT INTERNATIONAL UNIVERSITY   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cannabis use disorder; Primary care; Screening test; Sensitivity and specificity; Validation

Indexed keywords

CANNABIS;

ADULT; AGE DISTRIBUTION; AREA UNDER THE CURVE; ARTICLE; CANNABIS ADDICTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DRUG SCREENING; DSM-IV; EDUCATIONAL STATUS; ETHNICITY; FEMALE; HEALTH CARE NEED; HEALTH CARE PERSONNEL; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MINI INTERNATIONAL DIAGNOSTIC INTERVIEW; POST HOC ANALYSIS; POSTTRAUMATIC STRESS DISORDER; PRIMARY MEDICAL CARE; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX RATIO; TWO ITEM SCREEN OF DRUG USE; VALIDATION STUDY; AGED; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; GOVERNMENT; MASS SCREENING; MIDDLE AGED; PRIMARY HEALTH CARE; PSYCHOLOGICAL RATING SCALE; UNITED STATES;

AGED; AREA UNDER CURVE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MASS SCREENING; MIDDLE AGED; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; ROC CURVE; SENSITIVITY AND SPECIFICITY; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 85063455794     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2019.02.010     Document Type: Article

References (41)

1. Adamson, S., Sellman, J.D., A prototype screening instrument for cannabis use disorder: the Cannabis Use Disorders Identification Test (CUDIT) in an alcohol-dependent clinical sample. Drug and Alcohol Review 22:3 (2003), 309–315, 10.1080/0959523031000154454.
2. Adamson, S.J., Kay-Lambkin, F.J., Baker, A.L., Lewin, T.J., Thornton, L., Kelly, B.J., Sellman, J.D., An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R)☆. Drug and Alcohol Dependence 110:1–2 (2010), 137–143, 10.1016/j.drugalcdep.2010.02.017.
3. Ballesteros, J., Duffy, J.C., Querejeta, I., Arino, J., Gonzalez-Pinto, A., Efficacy of brief interventions for hazardous drinkers in primary care: systematic review and meta-analyses. Alcoholism, Clinical and Experimental Research 28:4 (2004), 608–618, 10.1097/01.ALC.0000122106.84718.67.
4. Blanco, C., Hasin, D.S., Wall, M.M., Flórez-Salamanca, L., Hoertel, N., Wang, S., Olfson, M., Cannabis use and risk of psychiatric disorders: prospective evidence from a us national longitudinal study. JAMA Psychiatry, 73(4), 2016, 388, 10.1001/jamapsychiatry.2015.3229.
5. Bonn-Miller, M.O., Heinz, A.J., Smith, E.V., Bruno, R., Adamson, S., Preliminary development of a brief cannabis use disorder screening tool: the cannabis use disorder identification test short-form. Cannabis and Cannabinoid Research 1:1 (2016), 252–261, 10.1089/can.2016.0022.
6. Bradley, K.A., Kivlahan, D.R., Zhou, X.-H., Sporleder, J.L., Epler, A.J., McCormick, K.A., Fihn, S.D., Using alcohol screening results and treatment history to assess the severity of at-risk drinking in Veterans Affairs primary care patients. Alcoholism, Clinical and Experimental Research 28:3 (2004), 448–455, 10.1097/01.ALC.0000117836.38108.38.
7. Bush, K., Kivlahan, D.R., McDonell, M.B., Fihn, S.D., Bradley, K.A., The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test Archives of Internal Medicine 158:16 (1998), 1789–1795.
8. Frayne, S.M., Phibbs, C.S., Saechao, F., Maisel, N.C., Friedman, S.A., Finlay, A., Haskell, S., Sourcebook: Women veterans in the veterans health administration. Volume 3. Sociodemographics, utilization, costs of care, and health profile. 2014, Women's Health Evaluation Initiative, Women's Health Services, Veterans Health Administration, Department of Veterans Affairs, Washington DC.
9. Ghitza, U.E., Tai, B., Challenges and opportunities for integrating preventive substance-use-care services in primary care through the affordable care act. Journal of Health Care for the Poor and Underserved 25:1A (2014), 36–45, 10.1353/hpu.2014.0067.
10. Grucza, R.A., Agrawal, A., Krauss, M.J., Cavazos-Rehg, P.A., Bierut, L.J., Recent trends in the prevalence of marijuana use and associated disorders in the United States. JAMA Psychiatry, 73(3), 2016, 300, 10.1001/jamapsychiatry.2015.3111.
11. Hall, W., Pacula, R., Cannabis use and dependence: Public health and public policy. 2003, Cambridge University Press, New York, NY.
12. Hall, W., Degenhardt, L., Adverse health effects of non-medical cannabis use. Lancet 374 (2009), 1383–1391.
13. Hasin, D.S., Kerridge, B.T., Saha, T.D., Huang, B., Pickering, R., Smith, S.M., Grant, B.F., Prevalence and correlates of dsm-5 cannabis use disorder, 2012-2013: Findings from the national epidemiologic survey on alcohol and related conditions–III. American Journal of Psychiatry 173:6 (2016), 588–599, 10.1176/appi.ajp.2015.15070907.
14. Hasin, D.S., O'Brien, C.P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Grant, B.F., DSM-5 criteria for substance use disorders: recommendations and rationale. American Journal of Psychiatry 170:8 (2013), 834–851, 10.1176/appi.ajp.2013.12060782.
15. Hasin, D.S., Saha, T.D., Kerridge, B.T., Goldstein, R.B., Chou, S.P., Zhang, H., Grant, B.F., Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry, 72(12), 2015, 1235, 10.1001/jamapsychiatry.2015.1858.
16. Kaner, E.F., Beyer, F.R., Muirhead, C., Campbell, F., Pienaar, E.D., Bertholet, N., Burnand, B., Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database of Systematic Reviews, 2018, 10.1002/14651858.CD004148.pub4.
17. Kerridge, B.T., Mauro, P.M., Chou, S.P., Saha, T.D., Pickering, R.P., Fan, A.Z., Hasin, D.S., Predictors of treatment utilization and barriers to treatment utilization among individuals with lifetime cannabis use disorder in the United States. Drug and Alcohol Dependence 181 (2017), 223–228, 10.1016/j.drugalcdep.2017.09.032.
18. Kiernan, M., Kraemer, H.C., Winkleby, M.A., King, A.C., Taylor, C.B., Do logistic regression and signal detection identify different subgroups at risk? Implications for the design of tailored interventions. Psychological Methods 6:1 (2001), 35–48, 10.1037//1082-989X.6.1.35.
19. Kraemer, H.C., Evaluating medical tests: objective and quantitative guidelines. 1992, Sage Publications, Newbury Park, Calif.
20. Lapham, G.T., Lee, A.K., Caldeiro, R.M., McCarty, D., Browne, K.C., Walker, D.D., Bradley, K.A., Frequency of cannabis use among primary care patients in Washington State. The Journal of the American Board of Family Medicine 30:6 (2017), 795–805, 10.3122/jabfm.2017.06.170062.
21. Lecrubier, Y., Sheehan, D.V., Weiller, E., Amorim, P., Bonora, I., Sheehan, K.H., Dunbar, G.C., The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. European Psychiatry 12:5 (1997), 224–231, 10.1016/S0924-9338(97)83296-8.
22. Moore, T.H., Zammit, S., Lingford-Hughes, A., Barnes, T.R., Jones, P.B., Burke, M., Lewis, G., Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. The Lancet 370:9584 (2007), 319–328, 10.1016/S0140-6736(07)61162-3.
23. Moyer, A., Finney, J.W., Swearingen, C.E., Vergun, P., Brief interventions for alcohol problems: A meta-analytic review of controlled investigations in treatment-seeking and non-treatment-seeking populations. Addiction 97 (2002), 279–292.
24. ProCon, 30 legal medical marijuana states and DC - medical marijuana - ProCon.org. Retrieved September 28, 2018, from https://medicalmarijuana.procon.org/view.resource.php?resourceID=000881, 2018.
25. Rogeberg, O., Elvik, R., The effects of cannabis intoxication on motor vehicle collision revisited and revised: Cannabis and motor vehicle collision risk. Addiction 111:8 (2016), 1348–1359, 10.1111/add.13347.
26. SAMHSA, Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. 2014.
27. SAMHSA, Impact of the DSM-IV to DSM-5 changes on the national survey on drug use and health. CBHSQ methodology report, 2016, Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD Retrieved from http://www.oas.samhsa.gov.
28. SAMHSA, Medications to treat opioid use disorder. Treatment Improvement Protocol (TIP) Series 63, 2018, Substance Abuse and Mental Health Services Administration, Rockville, MD.
29. Saunders, J.B., Aasland, O.G., Babor, T.F., de la Fuente, J.R., Grant, M., Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 88:6 (1993), 791–804, 10.1080/0959523021000002688.
30. Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., Dunbar, G.C., The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry 59:Suppl. 20 (1998), 22–33 quiz 34-57.
31. Sheehan, D.V., Lecrubier, Y., Harnett Sheehan, K., Janavs, J., Emmanuelle, W., Keskiner, A., Dunbar, G.C., The validity of the Mini International Neuropsychiatric Inteview (MINI) according to the SCID-P and its reliability. European Psychiatry 12:5 (1997), 232–241, 10.1016/S0924-9338(97)83297-X.
32. Smith, P.C., Schmidt, S.M., Allensworth-Davies, D., Saitz, R., A single-question screening test for drug use in primary care. Archives of Internal Medicine 170:13 (2010), 1155–1160, 10.1001/archinternmed.2010.140.
33. Tiet, Q.Q., Finney, J.W., Moos, R.H., Screening psychiatric patients for illicit drug use disorders and problems. Clinical Psychology Review 28:4 (2008), 578–591, 10.1016/j.cpr.2007.08.002.
34. Tiet, Q.Q., Leyva, Y.E., Moos, R.H., Frayne, S.M., Osterberg, L., Smith, B., Screen of drug use: diagnostic accuracy of a new brief tool for primary care. JAMA Internal Medicine, 2015, 10.1001/jamainternmed.2015.2438.
35. USPSTF, Screening and behavioral counseling interventions in primary care to reduce alcochol misuse: Recommendation statement. Vol. 140, 2004, 554–556.
36. USPSTF, Screening in primary care settings for illicit drug use: assessment of screening instruments — A supplemental evidence update for the u.s. preventive services task force. Evidence Synthesis No. 58, Part 2. AHRQ Publication No. 08–05108-EF-2, 2008, January, Agency for Healthcare Research and Quality, Rockville, Maryland.
37. USPSTF, Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: An updated systematic review. 2018, Agency for Healthcare Research and Quality, Rockville, MD.
38. Veterans Health Administration, FY05 VHA performance measure: 15b. Substance use disorder. 2004, Department of Veterans Affairs. Office of Quality and Performance, Washington, DC.
39. Volkow, N.D., Baler, R.D., Compton, W.M., Weiss, S.R.B., Adverse Health Effects of Marijuana Use. New England Journal of Medicine 370:23 (2014), 2219–2227, 10.1056/NEJMra1402309.
40. World Health Organization, Composite international diagnostic interview (CIDI), Version 1.0. 1990, World Health Organization.
41. World Health Organization, The alcohol, smoking and substance involvement screenign test (ASSIST): Guidelines for use in primary care. 2003, World Health Organization, Geneva, Switzerland, 1–44.